BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 16222109)

  • 1. Extension of ductal carcinoma in situ: histopathological association with MR imaging and mammography.
    Shiraishi A; Kurosaki Y; Maehara T; Suzuki M; Kurosumi M
    Magn Reson Med Sci; 2003 Dec; 2(4):159-63. PubMed ID: 16222109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is breast magnetic resonance imaging (MRI) useful for diagnosis of additional sites of disease in patients recently diagnosed with pure ductal carcinoma in situ (DCIS)?
    Benveniste AP; Ortiz-Perez T; Ebuoma LO; Sepulveda KA; Severs FJ; Roark A; Wang T; Sedgwick EL
    Eur J Radiol; 2017 Nov; 96():74-79. PubMed ID: 29103479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determination of the presence and extent of pure ductal carcinoma in situ by mammography and magnetic resonance imaging.
    Menell JH; Morris EA; Dershaw DD; Abramson AF; Brogi E; Liberman L
    Breast J; 2005; 11(6):382-90. PubMed ID: 16297080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preoperative MRI of pure intraductal breast carcinoma--a valuable adjunct to mammography in assessing cancer extent.
    Santamaría G; Velasco M; Farrús B; Zanón G; Fernández PL
    Breast; 2008 Apr; 17(2):186-94. PubMed ID: 17964786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preoperative prediction of the size of pure ductal carcinoma in situ using three imaging modalities as compared to histopathological size: does magnetic resonance imaging add value?
    Daniel OK; Lim SM; Kim JH; Park HS; Park S; Kim SI
    Breast Cancer Res Treat; 2017 Jul; 164(2):437-444. PubMed ID: 28439735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The diagnostic sensitivity of dynamic contrast-enhanced magnetic resonance imaging and breast-specific gamma imaging in women with calcified and non-calcified DCIS.
    Kim JS; Lee SM; Cha ES
    Acta Radiol; 2014 Jul; 55(6):668-75. PubMed ID: 24043881
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of preoperative breast MRI in ductal carcinoma in situ for prediction of the presence and assessment of the extent of occult invasive component.
    Nori J; Meattini I; Giannotti E; Abdulcadir D; Mariscotti G; Calabrese M; Angelino F; Chiesa F; Saieva C; Vanzi E; Boeri C; Bianchi S; Sanchez L; Orzalesi L; Casella D; Susini T; Livi L
    Breast J; 2014; 20(3):243-8. PubMed ID: 24750509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of mammography, ultrasound, and MRI in size assessment of ductal carcinoma in situ with histopathologic correlation.
    Baek SH; Choi WJ; Cha JH; Kim HH; Shin HJ; Chae EY
    Acta Radiol; 2017 Dec; 58(12):1434-1441. PubMed ID: 28281788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ductal carcinoma in situ: is there a role for MRI?
    Zuiani C; Francescutti GE; Londero V; Zunnui I; Bazzocchi M
    J Exp Clin Cancer Res; 2002 Sep; 21(3 Suppl):89-95. PubMed ID: 12585661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Three-dimensional RODEO breast MR imaging of lesions containing ductal carcinoma in situ.
    Soderstrom CE; Harms SE; Copit DS; Evans WP; Savino DA; Krakos PA; Farrell RS; Flamig DP
    Radiology; 1996 Nov; 201(2):427-32. PubMed ID: 8888235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DCIS of the breast: The value of preoperative MRI.
    Doyle AJ; Prakash S; Wang K; Cranshaw I; Taylor E; Oldfield R
    J Med Imaging Radiat Oncol; 2016 Apr; 60(2):194-8. PubMed ID: 26810138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Accuracy of Breast Magnetic Resonance Imaging Compared to Mammography in the Preoperative Detection and Measurement of Pure Ductal Carcinoma In Situ: A Retrospective Analysis.
    Preibsch H; Beckmann J; Pawlowski J; Kloth C; Hahn M; Staebler A; Wietek BM; Nikolaou K; Wiesinger B
    Acad Radiol; 2019 Jun; 26(6):760-765. PubMed ID: 30149976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dynamic contrast-enhanced MRI reveals the extent and the microvascular pattern of breast ductal carcinoma in situ.
    Santamaría G; Velasco M; Farrús B; Caparrós FX; Fernández PL
    Breast J; 2013; 19(4):402-10. PubMed ID: 23758454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sensitivity of breast MRI for ductal carcinoma in situ appearing as microcalcifications only on mammography.
    Rinaldi P; Buccheri C; Giuliani M; Bufi E; Romani M; Patrolecco F; Belli P; Bonomo L
    Clin Imaging; 2016; 40(6):1207-1212. PubMed ID: 27618803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Value of pre-operative breast MRI for the size assessment of ductal carcinoma in situ.
    Proulx F; Correa JA; Ferré R; Omeroglu A; Aldis A; Meterissian S; Mesurolle B
    Br J Radiol; 2016; 89(1058):20150543. PubMed ID: 26568438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic accuracy of mammography, clinical examination, US, and MR imaging in preoperative assessment of breast cancer.
    Berg WA; Gutierrez L; NessAiver MS; Carter WB; Bhargavan M; Lewis RS; Ioffe OB
    Radiology; 2004 Dec; 233(3):830-49. PubMed ID: 15486214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of ductal carcinoma in situ with mammography, breast specific gamma imaging, and magnetic resonance imaging: a comparative study.
    Brem RF; Fishman M; Rapelyea JA
    Acad Radiol; 2007 Aug; 14(8):945-50. PubMed ID: 17659240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improvement in DCIS detection rates by MRI over time in a high-risk breast screening study.
    Warner E; Causer PA; Wong JW; Wright FC; Jong RA; Hill KA; Messner SJ; Yaffe MJ; Narod SA; Plewes DB
    Breast J; 2011; 17(1):9-17. PubMed ID: 21251121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histopathological characteristics of breast ductal carcinoma in situ and association with imaging findings.
    Tang X; Yamashita T; Hara M; Kumaki N; Tokuda Y; Masuda S
    Breast Cancer; 2016 May; 23(3):491-8. PubMed ID: 25644245
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of false-negative cases of breast MR imaging in women with a familial or genetic predisposition.
    Obdeijn IM; Loo CE; Rijnsburger AJ; Wasser MN; Bergers E; Kok T; Klijn JG; Boetes C
    Breast Cancer Res Treat; 2010 Jan; 119(2):399-407. PubMed ID: 19876732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.